Submission Development & Support:

  PDi can successfully develop, compile and support regulatory submissions (ANDS, CTA) or post-approval submissions (SNDS).
PDi utilizes its network of experts for protocol design, clinical trial project management, and integrated study report writing.
PDi provides in-house expertise on most aspects of chemistry and manufacturing documentation development and submission (CMC and DMF).
PDi has experience in preparing electronic submissions.

 


a. Canadian Strategic Planning & Agency Representation
b. Preclinical & Clinical Development
c. Submission Development & Support
d. Post-Approval Consultation